Who Holds Bolt Biotherapeutics, Inc. (BOLT)? 23 Institutional Holders, Q2 2026
Managers with more than $100 million in US equities report their holdings on Form 13F within 45 days of each quarter end. Quarter ended 30 Jun 2026: 23 holders, $2 million in total.
Largest holders
The 23 largest by value. Change in shares against Q1 2026.
| Manager | Shares | Value | Change | |
|---|---|---|---|---|
| Sofinnova Investments, Inc. | 137,721 | $530,226 | +0% | 13F |
| RENAISSANCE TECHNOLOGIES LLC | 98,625 | $379,706 | +28% | 13F |
| Vivo Capital, LLC | 72,414 | $278,794 | +0% | 13F |
| CITADEL ADVISORS LLC | 56,903 | $219,077 | +463% | 13F |
| T3 Companies, LLC | 38,000 | $146,300 | +0% | 13F |
| Board of Trustees of The Leland Stanford Junior University | 35,977 | $138,511 | +0% | 13F |
| Pfizer Inc | 31,305 | $133,832 | +0% | 13F |
| Lynx1 Capital Management LP | 30,800 | $118,580 | +0% | 13F |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 27,500 | $105,875 | +0% | 13F |
| GEODE CAPITAL MANAGEMENT, LLC | 19,119 | $73,622 | -34% | 13F |
| Shay Capital LLC | 15,438 | $59,436 | +4% | 13F |
| BlackRock, Inc. | 9,711 | $37,388 | +0% | 13F |
| VANGUARD CAPITAL MANAGEMENT LLC | 7,060 | $27,181 | +0% | 13F |
| Nan Fung Group Holdings Ltd | 5,000 | $19,250 | -83% | 13F |
| MORGAN STANLEY | 3,145 | $12,108 | -1% | 13F |
| VANGUARD FIDUCIARY TRUST CO | 3,095 | $11,916 | +0% | 13F |
| NewEdge Advisors, LLC | 2,530 | $9,740 | New | 13F |
| Tower Research Capital LLC (TRC) | 1,710 | $6,584 | +56% | 13F |
| UBS Group AG | 255 | $982 | -68% | 13F |
| SBI Securities Co., Ltd. | 130 | $501 | +1200% | 13F |
| JPMORGAN CHASE & CO | 42 | $165 | +0% | 13F |
| CITIGROUP INC | 41 | $158 | New | 13F |
| BARCLAYS PLC | 6 | $23 | +0% | 13F |
Questions and answers
- How many institutions hold Bolt Biotherapeutics, Inc.?
- 23 managers reported Bolt Biotherapeutics, Inc. on Form 13F for the quarter ended 30 June 2026, against 24 the quarter before.
- Who is the largest institutional holder of Bolt Biotherapeutics, Inc.?
- Sofinnova Investments, Inc., with 137,721 shares worth $530,226 on its 13F for Q2 2026.
- How many institutions bought or sold out of Bolt Biotherapeutics, Inc. in Q2 2026?
- 2 managers reported a new position and 3 reported none after holding it the quarter before.
Source: SEC EDGAR, Form 13F (public domain). Counts and values as filed. Cite this page: Tamarly Intelligence, "Who holds Bolt Biotherapeutics, Inc., Q2 2026", https://app.tamarly.ai/holders/bolt-biotherapeutics, built from SEC EDGAR.
Research from public records, not investment advice. Tamarly holds no investment positions. By reading these pages you accept the Terms of Use; figures can be late or wrong, so check the linked source before relying on one. Terms and policies.